Biotin Dosage Guide: Protocols, Calculator & Safety
Everything you need to know about Biotin dosing — protocols, safety, and where to buy.
Dosage Calculator
Calculate exact dosing for Biotin.
Dosing Protocols
Beginner — routine dietary adequacy. Most adults with varied diets including eggs, meat, fish, nuts, and vegetables meet the adult AI (30 μg/day) without supplementation; colonic bacterial synthesis adds substantial biotin beyond dietary contribution. A basic multivitamin containing 30-300 μg biotin covers any gaps. Food sources: cooked eggs (egg yolk is rich; raw egg whites are problematic due to avidin), beef liver (exceptionally rich — 30 μg per ounce), salmon, pork, chicken, yeast, nuts (almonds, peanuts), seeds (sunflower), sweet potatoes, avocado, cauliflower, spinach, mushrooms. Avoid raw egg white consumption given avidin-mediated biotin binding. Pregnancy (30 μg AI) and lactation (35 μg AI) are covered by standard prenatal vitamins. No high-dose biotin at beginner tier.
Intermediate — clinical replacement or specific indications. For long-term anticonvulsant therapy (phenytoin, carbamazepine, phenobarbital, primidone), biotin 300 μg to 5 mg/day is reasonable prophylaxis given measurable biotin depletion with chronic therapy. For brittle nail syndrome (confirmed onychorrhexis), biotin 2.5 mg/day for 6-9 months has modest open-label evidence of clinical improvement (Colombo 1990). For uncombable hair syndrome (a specific pediatric entity), biotin 2.5-5 mg/day. For hyperemesis gravidarum, biotin 1-3 mg/day as part of broader vitamin repletion. For acquired biotin deficiency (confirmed by clinical features + laboratory), 1-10 mg/day for 2-8 weeks usually resolves the deficit. For generic hair/skin/nails complaints, evidence is thin — reasonable trial of 2.5-5 mg/day for 6 months is low-risk but should not displace evidence-based dermatology (finasteride, minoxidil, spironolactone for appropriate patients). Always remember laboratory assay interference: discontinue supplementation 24-72 hours before any laboratory testing and disclose biotin use to clinicians. For partial biotinidase deficiency, 1-5 mg/day lifelong. For chronic hemodialysis, 30-300 μg/day supplementation is standard practice.
Advanced — high-dose genetic disorder and specialist metabolic protocols. For profound biotinidase deficiency detected by newborn screening, lifelong oral biotin 5-10 mg/day is standard of care with excellent outcomes. Dose maintained throughout life, throughout pregnancy, and into old age. Patients should wear medical alert identification given the metabolic emergency risk of biotin cessation. For holocarboxylase synthetase deficiency, biotin 10-80 mg/day under metabolic specialist supervision; response varies by mutation. For biotin-thiamine-responsive basal ganglia disease (SLC19A3), biotin 5-10 mg/kg/day plus thiamine 10-40 mg/kg/day during acute crises and maintenance; see the Thiamine entry. For propionic acidemia, methylmalonic acidemia, 3-methylcrotonylglycinuria, biotin is one component of multi-agent protocols including protein/amino acid restriction, L-carnitine, and (for B12-responsive methylmalonic acidemia) hydroxycobalamin. For progressive multiple sclerosis, the former MD1003 300 mg/day protocol is NO LONGER recommended following the negative SPI2 trial (2020); patients previously on MD1003 should taper off and return to standard MS therapy; high-dose biotin should be actively discouraged for MS. Specialist metabolic physician supervision required for all high-dose protocols, and patients must understand and disclose biotin use for any laboratory testing throughout life.
Commonly Stacked With
Biotin stacks with several other compounds in biologically meaningful ways, though the pairings are less prominent than for other B vitamins. B-complex co-administration: biotin sits alongside B1 (thiamine), B2 (riboflavin), B3 (niacin), B5 (pantothenic acid), B6 (pyridoxine), B9 (folate), and B12 (cobalamin) in multicofactor metabolic pathways; most multivitamins include 30-300 μg biotin covering AI range. Biotin + pantothenic acid + α-lipoic acid: all three use the sodium-dependent multivitamin transporter (SMVT, SLC5A6) for cellular uptake, creating a theoretical competitive uptake interaction; at typical supplement doses this is not clinically relevant. Biotin + thiamine for biotin-thiamine-responsive basal ganglia disease (SLC19A3 mutations): combined biotin 5-10 mg/kg/day plus thiamine 10-40 mg/kg/day is the standard pediatric metabolic protocol — see the Thiamine entry for this genetic disorder. Biotin + L-carnitine for propionic acidemia and related organic acidemias, though these disorders are fundamentally propionyl-CoA carboxylase deficiencies rather than biotin deficiencies. Biotin + protein restriction + carnitine is the standard triad for managing organic acidemias where biotin-dependent carboxylase dysfunction contributes. Biotin + zinc + selenium for hair and nail concerns is common in cosmetic formulations; the rationale is the role of these nutrients in keratin formation (zinc), oxidative stress (selenium), and cofactor support (biotin), though evidence for the combination is limited. Biotin + riboflavin + niacin for mitochondrial support in specific metabolic contexts — carboxylases (biotin), dehydrogenases (riboflavin/FAD), and electron carriers (niacin/NAD+) all converge on intermediary metabolism. Biotin + inositol: marketed together for PCOS and metabolic syndrome, though evidence for the combination is limited. Biotin + pyridoxine (B6): both involved in amino acid catabolism, combined in standard B-complex. Biotin + alpha-lipoic acid: see the Alpha-Lipoic Acid entry; both support energy metabolism via different cofactor mechanisms. Biotin + CoQ10 + creatine: mitochondrial biogenesis stack occasionally used in metabolic medicine, without specific high-quality evidence for the combination. Anticonvulsants: phenytoin, carbamazepine, phenobarbital, primidone deplete biotin status, warranting supplementation at 100-300 μg/day. Isotretinoin: may modestly reduce biotin status. Antibiotics: may reduce colonic bacterial biotin synthesis; not usually clinically important unless combined with another biotin-risk factor. Raw egg whites: avidin in raw egg whites binds biotin with extraordinary affinity and prevents absorption; cooked eggs are fine. The cleanest stacking summary: biotin pairs with the B-complex for general adequacy; with thiamine specifically for biotin-thiamine-responsive basal ganglia disease; with protein restriction + carnitine for organic acidemias; and with zinc/selenium/other trace minerals in cosmetic combinations of uncertain added value. See the Thiamine, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, and Choline entries for the broader B-complex network; Alpha-Lipoic Acid for parallel SMVT transport and cofactor context; CoQ10 for mitochondrial bioenergetic co-supports; Zinc and Magnesium for the trace mineral context.
Side Effects & Safety
Contraindications
There are no absolute contraindications to oral biotin at AI-range or therapeutic doses; the compound is among the safest vitamins known with no direct dose-limiting toxicity established. Relative contraindications and cautions: **Known hypersensitivity** to biotin or to excipients in a particular formulation (extremely rare). **Imminent laboratory testing with streptavidin-biotin immunoassays**: discontinue biotin 24-72 hours before testing (longer for very high-dose use) to avoid false results that could delay or misdirect clinical care — this is the single most important practical caution and applies particularly to troponin (MI evaluation), TSH/T4/T3 (thyroid evaluation), hCG (pregnancy testing), PSA, vitamin D, sex hormones, and cardiac markers. **Progressive multiple sclerosis**: high-dose biotin (MD1003 protocol, 300 mg/day) is no longer recommended after the failed SPI2 trial; patients on this regimen should taper off. **Pregnancy**: AI-range biotin (30 μg/day) is safe and required; high-dose biotin supplementation beyond standard prenatal multivitamin is generally not needed, and for women with biotinidase deficiency, continuation of lifelong biotin therapy throughout pregnancy is appropriate. **Breastfeeding**: AI-range biotin supports maternal and infant needs. **Pediatric use**: AI-range biotin is essential; biotinidase/HCS deficiency high-dose protocols are appropriate under metabolic specialist care; generic high-dose biotin in children for cosmetic indications lacks evidence and should generally be avoided. **Chronic long-term anticonvulsant therapy**: supplementation at 300 μg to 5 mg/day is reasonable prophylaxis for subclinical depletion. **No clinically important absolute drug-drug contraindications** to biotin supplementation. **Renal failure**: no dose adjustment generally needed; biotin is poorly dialyzed and dialysis patients may benefit from modest supplementation. **Hepatic failure**: no dose adjustment needed. The principal practical caution remains laboratory assay interference — patients must disclose biotin use at every clinical encounter involving laboratory testing, and clinicians should ask about biotin supplementation when laboratory results conflict with clinical presentation.
Additional Notes
The adult adequate intake (AI) for biotin is 30 μg/day for men and women, 30 μg/day in pregnancy, 35 μg/day in lactation. Pediatric AI scales from 5 μg/day in infants to 25 μg/day in adolescents. There is no formally established tolerable upper intake level because of absent toxicity signal across the studied dose range. Oral absorption is efficient at physiologic intakes via SMVT (SLC5A6); at pharmacologic doses (mg range), passive diffusion contributes. Plasma biotin half-life is relatively short but tissue retention via covalent carboxylase attachment is long — whole-body biotin turnover is measured in weeks. Food sources: cooked eggs (one large egg yolk ≈ 10-15 μg, but raw egg white avidin blocks biotin), beef liver (30 μg per ounce — exceptional), salmon, pork, chicken breast, fortified cereals, yeast (nutritional or Brewer''s), almonds, peanuts, sunflower seeds, sweet potatoes, avocado, cauliflower, spinach, mushrooms. Standard tablets: 300 μg, 1 mg, 2.5 mg, 5 mg, 10 mg, and higher doses for specific indications. Commercial "hair/skin/nails" products typically contain 2,500-10,000 μg (2.5-10 mg); MS formerly used 100 mg tablets in the MD1003 protocol. Store at room temperature; biotin is relatively stable to heat and light (unlike riboflavin). Half-life extends with repeated dosing because of protein binding. Urinary excretion is low at physiologic intakes but increases proportionally at high doses. Functional status assessment: plasma biotin (limited availability), urinary 3-hydroxyisovaleric acid (elevated in biotin deficiency as biomarker of MCC insufficiency), lymphocyte propionyl-CoA carboxylase activity. The critical monitoring issue is laboratory assay interference: discontinue biotin 24-72 hours (longer for very high doses) before any laboratory testing that uses streptavidin-biotin capture chemistry.
Frequently Asked Questions
What is the recommended Biotin dosage?
Dosage for Biotin varies by protocol. Consult a qualified healthcare provider.
How often should I take Biotin?
Administration frequency depends on the specific protocol. Consult current research literature.
Does Biotin need to be cycled?
Cycling requirements depend on the protocol. Follow established research guidelines.
What are Biotin side effects?
Biotin has an exceptionally clean direct safety profile — no established tolerable upper intake level, no dose-limiting toxicity reported at doses up to 300 mg/day, and minimal side effect signal in decades of clinical use. The practical safety concern is not direct toxicity but **laboratory assay interference**, which creates clinically important risks when undisclosed. **Laboratory assay interference**. The FDA issued a safety communication in November 2017 warning that biotin can interfere with clinical laboratory tests that use streptavidin-biotin capture chemistry. At pharmacologic biotin doses (as low as 5-10 mg/day, dramatically at 30-300 mg/day), biotin plasma concentrations can saturate assay reagents and produce falsely high or falsely low results. Affected assays include: troponin (false low, risking delayed MI diagnosis — this is the highest-stakes interference), thyroid panel (TSH falsely low, T4/T3 falsely high — looks like hyperthyroidism), thyroid autoantibodies, vitamin D 25-OH (falsely high), hCG (both directions), PSA, parathyroid hormone, cortisol, sex hormones (testosterone, estradiol, progesterone), and many others. Hospital laboratories have since 2017 implemented mitigation strategies including patient biotin-use questionnaires, sample pretreatment with streptavidin beads, switching to non-biotin-based assay platforms, and clinical alert systems. Practical patient guidance: disclose biotin supplementation to any clinician ordering labs; stop biotin 24-72 hours before routine labs (longer for very high-dose use); in urgent/emergency settings, disclose biotin use immediately because biotin-free troponin assays or sample pretreatment may be available. A woman in early pregnancy taking high-dose "hair and nails" biotin whose hCG is falsely low may be told she is not pregnant; a chest-pain patient taking the same supplement whose troponin is falsely low may be prematurely discharged — these are the documented clinically-important interference scenarios. **Direct toxicity**. No dose-limiting toxicity has been established for biotin up to 300 mg/day. Rare case reports of minor GI upset, acne breakout, and insomnia exist at high doses. One unusual case report described eosinophilic pleuropericardial effusion in a patient on combined biotin + pantothenic acid at high doses. These are edge cases; most users tolerate high-dose biotin without symptom. **Drug interactions**. Anticonvulsants (phenytoin, carbamazepine, phenobarbital, primidone) increase biotin catabolism and may require supplementation. Chronic antibiotics (especially sulfonamides) can reduce colonic bacterial biotin synthesis. Biotin does not have clinically important interactions with most common medications. **Pregnancy and lactation**. Biotin AI (30 μg/day in pregnancy, 35 μg/day in lactation) is delivered by standard prenatal vitamins. High-dose biotin has not shown teratogenicity but is generally not needed. Hyperemesis gravidarum can produce biotin deficiency requiring repletion. **Pediatric use**. Biotin is essential; biotinidase deficiency newborn screening initiates lifelong biotin therapy at 5-10 mg/day with excellent outcomes. Holocarboxylase synthetase deficiency requires 10-80 mg/day under metabolic specialist care. Generic pediatric biotin supplementation at AI range via multivitamin is appropriate; pharmacologic doses for hair/skin indications in children lack evidence. **The MD1003 progressive MS story.** The 300 mg/day MD1003 formulation for progressive MS produced no dose-limiting direct toxicity in the SPI and SPI2 trials, but the laboratory assay interference was clinically significant — patients on MD1003 had dramatic false readings on thyroid tests, troponin, and other biotin-sensitive assays. This contributed to discontinuation of the MS program and is a practical reason to avoid very high-dose biotin outside rare specific indications. **Pregnancy with high-dose biotin for biotinidase deficiency** is appropriate — women with biotinidase deficiency must continue biotin therapy throughout pregnancy to maintain carboxylase function and prevent metabolic decompensation. **Allergic reactions** to biotin are extremely rare. The cleanest safety summary: biotin has essentially no direct toxicity at any clinically used dose, but the laboratory assay interference is a genuine patient safety issue that should prompt disclosure before any lab testing and routine cessation of supplementation 24-72 hours before testing. High-dose biotin for unproven cosmetic indications should be discouraged given the laboratory risk combined with absent efficacy evidence.
Where can I buy Biotin?
Visit our vendor directory to find trusted sources for Biotin.
Free 2026 Peptide Cheat Sheet — 50 pages, PDF
Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.
